High FN1 expression correlates with gastric cancer progression
Authors:
- 18 October 2022
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 239, 154179
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Matrix control of pancreatic cancer: New insights into fibronectin signalingCancer Letters, 2016
- Stromal-Based Signatures for the Classification of Gastric CancerCancer Research, 2016
- Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcomeMolecular and Clinical Oncology, 2016
- Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancerHuman Pathology, 2013
- Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancerGut, 2012
- Expression of Mesenchymal Markers Vimentin and Fibronectin: The Clinical Significance in Esophageal Squamous Cell CarcinomaAnnals of Surgical Oncology, 2012
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and ElaborationPLOS Medicine, 2012
- Fibronectin matrix-mediated cohesion suppresses invasion of prostate cancer cellsBMC Cancer, 2012
- 7th Edition of the AJCC Cancer Staging Manual: StomachAnnals of Surgical Oncology, 2010
- Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancerJournal of Clinical Pathology, 2006